<DOC>
	<DOCNO>NCT00595205</DOCNO>
	<brief_summary>GSK Biologicals ' rotavirus vaccine , Rotarix™ recommend universal use target infant Expanded Program Immunization ( EPI ) Mexico . This protocol describe Phase IV safety study Mexico design evaluate safety profile Rotarix™ regard intussusception ( IS ) . The data generate study useful public health officer policy maker confirm safety profile Rotarix™ .</brief_summary>
	<brief_title>Intussusception Surveillance After Rotarix Introduction Mexico</brief_title>
	<detailed_description>Rationale amendment 3 : The finding first year implementation active surveillance show Lower Respiratory Tract-Related Post-Neonatal ( LRTI ) Mortality case could include study , grieve parent refuse participate study . The European Medicines Agency Marketing Authorization Holders ( EMEA MAH ) also generate substantial amount additional clinical post-marketing safety data throughout world , clearly indicate absence safety signal consider LTRI-related fatality . Therefore surveillance LRTI mortality case remove study design . The number sit reduce approximately 230 60 90 order reflect mention change reduce need many site . Additionally , passive surveillance IS case IMSS database feasible , due restriction IMSS internal policy current limitation databases linkage structure ability . Lastly , SAEs reporting procedure adjust accord Council International Organizations Medical Sciences ( CIOMS ) Working Group V , 2001 publication expedite safety reporting study . Design This post marketing , Phase IV , observational , prospective , self-controlled case series , vaccine safety study include : ) hospital-based surveillance monitor occurrence IS active surveillance ; b ) self-controlled case series ( SCCS ) design/analysis assess temporal association Rotarix™ IS ascertain active surveillance . The aim active hospital-based surveillance system identify definite IS case child young one year age ( child ineligible day first birthday ) among IMSS member . Surveillance conduct approximately 60 90 IMSS health facility pediatric surgery service . Study participation child fit surveillance case definition IS include parental/guardian/legal representative interview , well review medical chart vaccination record . Additional medical information collect medical record review hospitalization child discharge .</detailed_description>
	<mesh_term>Intussusception</mesh_term>
	<criteria>A child 's clinical episode define IS case deem eligible study he/she meet follow criterion : Subject IMSS affiliate Subject treated/has treated/has refer treatment one IMSS hospitals/medical facility IS study period . Male female child &lt; one year age time diagnosis IS ( child becomes ineligible day first birthday ) Subject diagnose definite IS base Brighton criterion Written inform consent obtain parent/guardian/legal representative subject Subjects meet criterion eligible inclusion study regardless whether subject radiographically surgically confirm case IS prior current episode .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>364 Days</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>vaccination</keyword>
	<keyword>intussusception</keyword>
	<keyword>Rotavirus</keyword>
	<keyword>vaccine</keyword>
</DOC>